Inhibitors of IDH1mut (IDH305 and FT-2102), IDH2mut (AG221), and pan-IDH1/2mut (AG881) are under investigation for CCA patients [38,39,40,41]. This evidence concerns the gene IDH1 and cholangiocarcinoma.